Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity

Franz Sellner, Sabine Thalhammer, Martin Klimpfinger, Franz Sellner, Sabine Thalhammer, Martin Klimpfinger

Abstract

Isolated pancreatic metastases of renal cell carcinoma (isPMRCC) are a rare manifestation of metastatic renal cell carcinoma (mRCC) characterized by two peculiarities: (1). The definite or at least long-term exclusive occurrence of metastases in the pancreas and (2). an unusual low tumour aggressiveness with slow tumour progression and consecutive, good treatment results. According to current knowledge, the exclusive occurrence of pancreatic metastases is due to a highly specific and highly selective seed and soil mechanism, which does not allow metastases settlement outside the pancreas, and whose detailed genetic/epigenetic causes are not yet elucidated. Recent studies have shed light on some of the pathways involved for the protracted course of the disease and highlighted a special genetic profile (lack of loss of 9p, lower weight genome instability index, low frequency of BAP1 alterations, and a high frequency of PBRM1 loss), which deviates from the conventional mRCC profile. Finally, the question of the reasons for the long-term relative genetic stability of the involved cell clones, which is an essential prerequisite for a favourable prognosis, remains unanswered.

Keywords: isolated pancreatic metastasis; organotropism; prognosis; renal cell carcinoma; seed and soil mechanism.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Search and selection strategy.
Figure 2
Figure 2
Kaplan–Meier survival curves; surgical treatment group (N = 415).

References

    1. Endo Y., Noda H., Watanabe F., Kato T., Kazikawa N., Ichida K., Kasahara N., Rikiyama T. A retrospective analysis of preoperative evaluation and surgical resection for metastatic tumors to the pancreas. Indian J. Surg. Oncol. 2019;10:251–257. doi: 10.1007/s13193-019-00905-w.
    1. Ito T., Takada R., Omoto S., Tsuda M., Masuda D., Kato H., Matsumoto T., Moriyama I., Okabe Y., Shiomi H., et al. Analysis of prognostic factors in pancreatic metastases. A multicentre retrospective analysis. Pancreas. 2018;47:1033–1039. doi: 10.1097/MPA.0000000000001132.
    1. Madkhali A.A., Shin S., Song K.B., Lee J.H., Hwang D.W., Park K.M., Lee Y.J., Kim S.C. Pancreatectomy for secondary metastasis of the pancreas: A single-institution experience. Medicine. 2018;97:e12653. doi: 10.1097/MD.0000000000012653.
    1. Yagi T., Hashimoto D., Taki K., Yamamura K., Chikamoto A., Ohmuraya M., Beppu T., Baba H. Surgery for metastatic tumors to the pancreas. Surg. Case Rep. 2017;3:31. doi: 10.1186/s40792-017-0308-0.
    1. Sperti C., Moletta L., Patanè G. Metastatic tumors to the pancreas: The role of surgery. World J. Gastrointest. Oncol. 2014;15:381–392. doi: 10.4251/wjgo.v6.i10.381.
    1. Untsch B.R., Allen P.J. Pancreatic metastectomy: The Memorial Sloan—Kettering experience and a review of the literature. J. Surg. Oncol. 2014;109:28–30. doi: 10.1002/jso.23460.
    1. Alzahrani M.A., Schmulewitz N., Grewal S., Lucas F.V., Turner K.O., McKenzie J.T., Sussman J.J., Ahmad S.A. Metastases to the pancreas: The experience of a high volume center and a review of the literature. J. Surg. Oncol. 2012;105:156–161. doi: 10.1002/jso.22009.
    1. Anderson B., Williams G.A., Sanford D.E., Liu J., Dageforde L.A., Hammill C.W., Fields R.C., Hawkins W.G., Strasberg S.M., Doyle M.B., et al. A 22-year experience with pancreatic resection for metastatic renal cell carcinoma. HPB. 2020;22:312–317. doi: 10.1016/j.hpb.2019.05.019.
    1. Niess H., Conrad C., Kleespies A., Haas F., Bao Q., Jauch K.W., Graeb C., Bruns C.J. Surgery for metastasis to the pancreas: Is it safe and effective? J. Surg. Oncol. 2013;107:859–864. doi: 10.1002/jso.23333.
    1. Hung J.H., Wang S.E., Shyr Y.M., Su C.H., Chen T.H., Wu C.W. Resection for secondary malignancy of the pancreas. Pancreas. 2012;41:121–129. doi: 10.1097/MPA.0b013e31821fc8f2.
    1. Konstantinidis I.T., Dursun A., Zheng H., Wargo J.A., Thayer S.P., Fernandez-del Castillo C., Warshaw A.L., Ferrone C.R. Metastatic tumors in the pancreas in the modern era. J. Am. Coll. Surg. 2010;211:749–753. doi: 10.1016/j.jamcollsurg.2010.08.017.
    1. Mourra N., Arrive L., Balladur P., Flejou J.F., Tiret E., Paye F. Isolated metastatic tumors to the pancreas. Hôpital St-Antoine experience. Pancreas. 2010;39:577–580. doi: 10.1097/MPA.0b013e3181c75f74.
    1. Reddy S., Edil B.H., Cameron J.L., Pawlik T.M., Herman J.M., Gilson M.M., Campbell K.A., Schulick R.D., Ahuja N., Wolfgang C.L. Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann. Surg. Oncol. 2008;15:3199–3206. doi: 10.1245/s10434-008-0140-7.
    1. Sweeney A.D., Wu M.F., Hilsenbeck S.G., Brunicardi C., Fisher W.E. Value of pancreatic resection for cancer metastatic to the pancreas. J. Surg. Res. 2009;156:189–198. doi: 10.1016/j.jss.2009.01.017.
    1. Strobel O., Hackert T., Hartwig W., Bergmann F., Hinz U., Wente M.N., Fritz S., Schneider L., Büchler M.W., Werner J. Survival data justifies resection for pancreatic metastases. Ann. Surg. Oncol. 2009;16:3340–3349. doi: 10.1245/s10434-009-0682-3.
    1. Sellner F., Thalhammer S., Klimpfinger M. Tumour evolution and seed and soil mechanism in pancreatic metastases of renal cell carcinoma. Cancers. 2021;13:1342. doi: 10.3390/cancers13061342.
    1. Adsay V.N., Andea A., Basturk O., Kilinc N., Nassar H., Cheng J.D. Secondary tumors of the pancreas: An analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527–535. doi: 10.1007/s00428-004-0987-3.
    1. Chikhladze S., Lederer A.K., Kühlbrey C.M., Hipp J., Sick O., Fichtner-Feigl S., Wittel U.A. Curative-intent pancreas resection for pancreatic metastases: Surgical and oncological results. Clin. Exp. Metastasis. 2020;37:313–324. doi: 10.1007/s10585-020-10029-z.
    1. Wiltberger G., Bucher J.N., Krenzien F., Benzing C., Atanasov G., Schmelzle M., Hau H.M., Bartels M. Extended resection in pancreatic metastases: Feasibility, frequency, and long-term outcome: A retrospective analysis. BMC Surg. 2015;15:126. doi: 10.1186/s12893-015-0114-1.
    1. Sellner F., Tykalsky N., De Santis M., Pont J., Klimpfinger M. Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: An indication for pancreatic surgery. Ann. Surg. Oncol. 2006;13:75–85. doi: 10.1245/ASO.2006.03.064.
    1. Sellner F. Isolated pancreatic metastases from renal cell carcinoma: An outcome of a special metastatic pathway or of a specific tumor cell selection? Clin. Exp. Metastasis. 2018;35:91–102. doi: 10.1007/s10585-018-9910-1.
    1. Sellner F. Isolated pancreatic metastases of renal cell carcinoma—A paradigm of a seed and soil mechanism: A literature analysis of 1034 observations. Front. Oncol. 2020;10:709. doi: 10.3389/fonc.2020.00709.
    1. Jenssen E. A metastatic hypernephroma to the pancreas. Acta Chir. Scand. 1952;104:177–180.
    1. Lawson L., Holt L., Rooke H. Recurrent duodenal haemorrhage from renal carcinoma. Br. J. Urol. 1966;38:133–137. doi: 10.1111/j.1464-410X.1966.tb09690.x.
    1. Franciosi R.A., Russo J. Renal cell carcinoma metastatic to the pancreas thirteen years following nephrectomy. Mil. Med. 1969;134:200–203. doi: 10.1093/milmed/134.3.200.
    1. Marquand J., Giraud B., Maliakas S. Pancreatic metastasis revealing a kidney neoplasm. J. Urol. Nephrol. 1971;77:595–601.
    1. Guttman F., Ross M., Lachance C. Pancreatic metastasis of renal cell carcinoma treated by total pancreatectomy. Arch. Surg. 1972;105:782–784. doi: 10.1001/archsurg.1972.04180110099026.
    1. Gillet M., Camelit G., Runser G., Clement D. Duodenopancreatic metastasis of kidney cancer revealed by digestive hemorrhage treated by cephalic duodeno-pancreatectomy. Chirurgie. 1974;100:226–230.
    1. Hermanutz K.D., Sonnenberg G.E. Late metastasis of a hypernephroid kidney carcinoma to the pancreas with tumor invasion to the duodenum. Fortschr. Röntgenstr. 1977;127:595–597. doi: 10.1055/s-0029-1230774.
    1. Saxon A., Gottesman J., Doolas A. Bilateral hypernephroma with solitary pancreatic metastasis. J. Surg. Oncol. 1980;13:317–322. doi: 10.1002/jso.2930130406.
    1. Yazaki T., Ishikawa S., Ogawa Y., Takahashi S., Nemoto S., Rinsho K., Kanoh S., Kitagawa R. Silent pancreatic metastasis from renal cell carcinoma diagnosed at arteriography. Acta Urol. Jpn. 1981;27:1517–1522.
    1. Py J.M., Arnaud J.P., Cinqualbre J., Adloff M., Bollack C. Pancreatic metastases of nephro-epitheliomas. Apropos of 2 cases. Acta Chir. Belg. 1984;84:117–121.
    1. Skaarup P., Jorgensen T., Larsen S. Asynchronous metastasizing renal cell carcinoma associated with progressive immune complex glomerulonephritis and proteinuria. Scand. J. Urol. Nephrol. 1984;18:351–356. doi: 10.3109/00365598409180210.
    1. Audisio R.A., La Monica G. Solitary pancreatic metastasis occurring 20 years after nephrectomy for carcinoma of the kidney. Tumori. 1985;71:197–200. doi: 10.1177/030089168507100217.
    1. Kishimoto H., Niumra Y., Okamoto K., Tsuchie K., Yamase H., Maeda S., Kamija J., Hasagawa H., Hayakawa N., Yamamoto M. A case of resected renal cell carcinoma with massive pancreatic metastasis. Jap. J. Cancer Clin. 1985;31:91–96.
    1. Amamiya H., Iizumi T., Yazaki T., Waku M., Yasuda H., Takada T., Shikata J., Nagai J. A solitary pancreatic metastasis from renal cell carcinoma. Hinyouki Geka. 1988;2:167–170.
    1. Carini M., Selli C., Barbanti G., Bianchi S., Muraro G. Pancreatic late recurrence of bilateral renal cell carcinoma after conservative surgery. Eur. Urol. 1988;14:258–260. doi: 10.1159/000472953.
    1. Hirano M., Douden K., Bantou H., Sakatoku M., Saitoh H., Tachikawa H., Kitagawa K., Yamahata T., Hirano A., Kawaguchi M., et al. Solitary pancreatic metastasis occuring 10 years after nephrectomy for carcinoma of the kidney. Tan Sui. 1988;9:233–237.
    1. Sharma S.K., Kumar A., Madhusoodnan P., Banerjee C., Suri S., Dhar M. Solitary pancreatic metastasis from renal cell carcinoma. A rare metastatic site. Indian J. Cancer. 1988;25:29–32.
    1. Guyenne C., Rat P., Haas O., Baudet J.G., Favre J.P. Triple metastase pancreatique d’un cancer du rein traitee par duodenopancreatectomie subtotale. Presse Med. 1989;18:231.
    1. Iwanami M., Nakayoshi A., Yagi H., Shimizu K., Kimura K., Suzuki K., Matsumoto K., Kai Y., Heno M., Sagawa F. A resected case of the asymptomatic pancreatic metastasis in the body and tail of the pancreas from renal cell carcinoma. J. Jpn. Panc. Soc. 1989;4:100–106.
    1. Roland C., van Heerden J. Nonpancreatic primary tumors with metastasis to the pancreas. Surg. Gynecol. Obstet. 1989;168:345–347.
    1. Simpson N.S., Mulholland C.K., Lioe T., Spence R. Late, solitary metastatic renal carcinoma in the pancreas. Ulster Med. J. 1989;58:198–199.
    1. Strijk S.P. Pancreatic metastases of renal cell carcinoma: Report of two cases. Gastrointest. Radiol. 1989;14:123–126. doi: 10.1007/BF01889175.
    1. Temellini F., Bavosi M., Lamarra M., Quagliarini P., Giuliani F. Pancreatic metastasis 25 years after nephrectomy for renal cancer. Tumori. 1989;75:503–504. doi: 10.1177/030089168907500522.
    1. Gohji K., Matsumoto O., Kamidono S. Solitary pancreatic metastasis from renal cell carcinoma. Hinyokika Kiyo. 1990;36:677–681.
    1. Terashima M., Abe H., Suga K., Matsuya F., Kobayashi K., Itoh S., Sasaki R., Kanno S., Saito K., Tomichi N., et al. Two cases of renal cell carcinoma metastasized to the pancreas and to the gallbladder. Jpn. J. Gastroenterol. Surg. 1990;23:1952–1956. doi: 10.5833/jjgs.23.1952.
    1. Furukawa T., Hattori R., Ohtake H., Souma T., Kinukawa T., Hirai K., Kimura J., Sakata T., Ishii M., Hayashi N., et al. A resectable case of pancreatic head metastasis from renal cell carcinoma. Hinyouki Geka. 1991;4:111–114.
    1. Kubo K., Morita J., Mizoe J., Ogawa H., Irie G. Renal cell carcinoma metastatic to the pancreas 8 years following nephrectomy. Jpn. J. Clin. Radiol. 1991;36:509–512.
    1. Nishida O., Matsunaga Y., Dekigai H., Um S., Hsieh C., Kimura F. Three elderly cases of renal cell carcinoma with pancreatic metastasis. Nippon Ronen Igakkai Zasshi. 1991;28:392–396. doi: 10.3143/geriatrics.28.392.
    1. Oka H., Hatayama T., Taki Y., Ueyama H., Hida S., Noguchi M. A resected case of renal cell carcinoma with metastasis to the pancreas. Hinyokika Kiyo. 1991;37:1531–1534.
    1. Tabata T., Kuroda Y., Nishimatsu S., Satoh Y. A resected case of pancreatic tumor metastasized from renal cell carcinoma. J. Jpn. Panc. Soc. 1991;6:245–250.
    1. Yamamoto S., Tobinaga K., Taketomi K., Kimino K., Ashizuka S., Kishikawa M. Pancreatic metastasis of renal cell carcinoma occurring 17 years after nephrectomy. J. Jpn. Soc. Clin. Surg. 1991;52:3006–3011. doi: 10.3919/ringe1963.52.3006.
    1. Fujii M., Kogawa T., Matsuyama K., Yamamoto H., Kaawahito Y., Iinuma S., Kokura S., Takemura S., Yoshikawa T., Kondo M., et al. A case of metastatic renal cell carcinoma to pancreas ten years after nephrectomy. J. Kyoto Pref. Univ. Med. 1992;101:589–596.
    1. Melo C.R., Melo I.S., Monteiro A.Z., de Mello E.S. Pancreatic metastasis from renal cell carcinoma. Arq. Gastroenterol. 1992;29:110–112.
    1. Nakagawa K., Tsuchiya T., Momono S., Sasaki Y., Sato T. A case of pancreatic metastasis of renal cell carcinoma. Jpn. J. Gastroenterol. Surg. 1992;25:2200–2204. doi: 10.5833/jjgs.25.2200.
    1. Rypens F., Van Gansbeke V., Lambilliotte J., Regemorter V., Verhest A., Struyven J. Pancreatic metastasis from renal cell carcinoma. Br. J. Radiol. 1992;65:547–548. doi: 10.1259/0007-1285-65-774-547.
    1. Stankard C., Karl R.C. The treatment of isolated pancreatic metastases from renal cell carcinoma: A surgical review. Am. J. Gastroenterol. 1992;87:1658–1660.
    1. Aikou S., Tokura Y., Yamafuji K., Takahashi T., Yoshibide O., Kishii K., Fujii S., Katsumata K., Tamiya M. A resected case of pancreatic metastasis from renal cell carcinoma presenting with acute duodenal bleeding. J. Jpn. Soc. Clin. Surg. 1993;54:2666–2672. doi: 10.3919/ringe1963.54.2666.
    1. Calmes J.M., Meyer A. Pancreatic hypernephroma manifested by a duodenal hemorrhage. Rev. Med. Suisse Romande. 1993;113:629–631.
    1. Ishikawa T., Horimi T., Majima K. A resected case of pancreatic tumor metastasized from renal cell carcinoma. A review of 11 cases in the Japanese and 13 cases in the foreign literature. J. Jpn. Soc. Clin. Surg. 1993;51:1642–1647.
    1. Kawaguchi T., Tsunoda T., Tanaka Y., Saika Y., Ohiani H., Fujii R., Zaitsu Y., Tanimura H., Takifuji K. A case of resection of a solitary pancreatic metastasis of renal cell carcinoma occuring 5 years after nephrectomy. J. Jpn. Panc. Soc. 1993;8:189–195.
    1. Marcote-Valdivieso E., Arlandis F., Baltasar A., Martinez C., Vierna G. Synchronous pancreatic metastasis of renal carcinoma. Rev. Esp. Enferm. Dig. 1993;83:471–473.
    1. Nan Y., Kuno N., Kurimoto K., Nakamura T., Kobayashi S. A resected case of pancreatic tumor metastasized from renal cell carcinoma diagnosed by endoscopic biopsy through the main pancreatic duct. Gastroenterol. Endosc. 1993;35:1380–1385.
    1. Oda K., Itoh J., Hachisuka K., Yamaguchi A., Isogai M., Utsunomiya H., Osamura Y., Watanabe K. Value of computer image analysis in improving ERCP images in metastatic tumor of the pancreas. AJR. 1993;161:885–886. doi: 10.2214/ajr.161.4.8372781.
    1. Reale D., Squillaci S., Guarino M., Milesi F., Forloni B., Vezzini V., Pascale M., Micoli G. Late pancreatic metastasis of renal carcinoma. Description of 2 cases and review of literature. Minerva Urol. Nefrol. 1993;45:183–186.
    1. Sauvanet A., Barthes T., Levy P., Flejou J.F. Late pancreatic metastasis from renal cell carcinoma. Pancreas. 1993;8:742–746. doi: 10.1097/00006676-199311000-00014.
    1. Takeuchi H., Konaga E., Harano M., Watanabe K., Takeuchi Y., Hara M., Mano S. Solitary pancreatic metastasis from renal cell carcinoma. Acta Med. Okayama. 1993;47:63–66. doi: 10.18926/AMO/31603.
    1. Vergara V., Marucci M., Marcarino C., Brunello F., Capussotti L. Metastatic involvement of the pancreas from renal cell carcinoma treated by surgery. Ital. J. Gastroenterol. 1993;25:388–390.
    1. Yanagisawa T., Nakayama K., Kashiwagi M., Tanaka J., Kashiwagi T., Mizusaki K., Itoh A., Akimoto H., Takahashi T., Aoki T., et al. Three cases of resectable pancreatic metastases from renal cell carcinoma. Geka Shinryo. 1993;35:651–655.
    1. Zugel N., Leipprand F., Weckermann D., Witte J. Solitäre Pankreaskopfmetastase bei hypernephroidem Carcinom. Fortschr. Med. 1994;112:388–390.
    1. Dousset B., Andant C., Guimbaud R., Roseau G., Tulliez M., Gaudric M., Palazzo L. Late pancreatic metastasis from renal cell carcinoma diagnosed by endoscopic ultrasonography. Surgery. 1995;117:591–594. doi: 10.1016/S0039-6060(05)80261-2.
    1. Fabre J., Rounanet P., Dagues F., Blanc F., Baumel H., Domergue J. Various features and surgical approach of solitary pancreatic metastasis from renal cell carcinoma. Eur. J. Surg. Oncol. 1995;21:683–686. doi: 10.1016/S0748-7983(95)96079-1.
    1. Onishi T., Ohishi Y., Iizuka N., Suzuki Y., Shirakawa H., Hatano T., Tomita M. Clinical characteristics of 7 renal cell carcinoma patients developing a solitary pancreatic metastasis after nephrectomy. Nippon Hinyokika Gakkai Zasshi. 1995;86:1538–1542.
    1. Orita M., Morita N., Hiraoka H., Noshima S., Takaimashi T., Esato K. A case of resected pancreatic metastasis from renal cell carcinoma 14 years after radical nephrectomy. J. Jpn. Panc. Soc. 1995;10:63–68.
    1. Takashi M., Takagi Y., Sakata T., Shimoji T., Miyake K. Surgical treatment of renal cell carcinoma metastases: Prognostic significance. Int. Urol. Nephrol. 1995;27:1–8. doi: 10.1007/BF02575213.
    1. Barras J.P., Baer H., Stenzl A., Czerniak A. Isolated late metastasis of a renal cell cancer treated by radical distal pancreatectomy. HPB Surg. 1996;10:51–53. doi: 10.1155/1996/56065.
    1. Hirota T., Tomida T., Iwasa M., Takahashi K., Kaneda M., Tamaki H. Solitary pancreatic metastasis occurring eight years after nephrectomy for renal cell carcinoma. A case report and surgical review. Int. J. Pancreatol. 1996;19:145–153. doi: 10.1007/BF02805229.
    1. Palazzo L., Borotto E., Cellier C., Roseau G., Chaussade S., Couturier D., Paolaggi J. Endosonographic features of pancreatic metastases. Gastrointest. Endosc. 1996;44:433–436. doi: 10.1016/S0016-5107(96)70095-0.
    1. Paz A., Koren R., Gal R., Wolloch Y. Late solitary pancreatic metastasis from renal cell carcinoma. Isr. J. Med. Sci. 1996;32:1319–1321.
    1. Chambers T., Fishman E., Hruban R. Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease. Clin. Imaging. 1997;21:40–42. doi: 10.1016/0899-7071(95)00066-6.
    1. Harrison L.E., Merchant N., Cohen A.M., Brennan M.F. Pancreaticoduodenectomy for nonperiampullary primary tumors. Am. J. Surg. 1997;174:393–395. doi: 10.1016/S0002-9610(97)00121-9.
    1. Robbins E.G., Franceschi D., Barkin J. Solitary metastatic tumors to the pancreas: A case report and review of the literature. Am. J. Gastroenterol. 1997;92:914–915.
    1. Adem C., Chetritt J., Guymar S., Bellil K., Ladouch-Badre A., Benlagha N., Bedossa P. Pancreatic metastasis of a renal adenocarcinoma. Apropos on 2 cases. Ann. Pathol. 1998;18:481–483.
    1. Altschuler E., Ray A. Spontaneous regression of a pancreatic metastasis of a renal cell carcinoma. Arch. Fam. Med. 1998;7:516–517. doi: 10.1001/archfami.7.6.516.
    1. Butturini G., Bassi C., Falconi M., Salvia R., Caldiron E., Iannucci A., Zamboni G., Grazinai R., Procacci C., Pederzoli P., et al. Surgical treatment of pancreatic metastases from renal cell carcinomas. Dig. Surg. 1998;15:241–246. doi: 10.1159/000018621.
    1. Gupta R.K., Lallu S., Delahunt B. Fine-needle aspiration cytology of metastatic clear-cell renal carcinoma presenting as a solitary mass in the head of the pancreas. Diagn. Cytopathol. 1998;19:194–197. doi: 10.1002/(SICI)1097-0339(199809)19:3<194::AID-DC8>;2-D.
    1. Hashimoto M., Watanabe G., Matsuda M., Dohi T., Tsurumaru M. Management of pancreatic metastases from renal cell carcinoma: Report of four resected cases. Hepatogastroenterology. 1998;45:1150–1154.
    1. Jingu K., Watanabe K., Yamamoto H., Fujita Y., Honda I., Watanabe S., Nagata M., Sugimoto K., Watanabe Y., Fujita Y., et al. Surgical treatment of a solitary pancreatic metastasis from renal cell carcinoma: Report of a case. Surg. Today. 1998;28:91–94. doi: 10.1007/BF02483616.
    1. Merkle E.M., Boaz T., Kolokythas O., Haaga J.R., Lewin J.S., Brambs H.J. Metastases to the pancreas. Br. J. Radiol. 1998;71:1208–1214. doi: 10.1259/bjr.71.851.10434919.
    1. Sahin M., Foulis A.A., Poon F.W., Imrie C.W. Late focal pancreatic metastasis of renal cell carcinoma. Dig. Surg. 1998;15:72–74. doi: 10.1159/000018591.
    1. Z’graggen K., Fernandez-del Castillo C., Rattner D., Sigala H., Warshaw A. Metastases to the pancreas and their surgical extirpation. Arch. Surg. 1998;133:413–417. doi: 10.1001/archsurg.133.4.413.
    1. Augustin H., Bacher H., Uggowitzer M., Ott A., Hubmer G., Mischinger H. Pancreatic metastases from renal cell carcinoma mimicking insulinomas. BJU Int. 1999;83:140–141. doi: 10.1046/j.1464-410x.1999.00855.x.
    1. Carucci L., Siegelman E., Feldman M. Pancreatic metastasis from clear cell renal carcinoma: Diagnosis with chemical shift MRI. J. Comput. Assist. Tomogr. 1999;23:934–936. doi: 10.1097/00004728-199911000-00018.
    1. Eriguchi N., Aoyagi S., Hara M., Miyazaki T., Hashino K., Imamura I., Jimi A., Naito H., Miyazaki T., Hashimo K., et al. A resected case of pancreatic metastasis from primary renal cell carcinoma. Kurume Med. J. 1999;46:119–122. doi: 10.2739/kurumemedj.46.119.
    1. Ng C.S., Loyer E.M., Iyer R.B., David C.L., DuBrow R.A., Charnsangavej C. Metastases to the pancreas from renal cell carcinoma: Findings on three-phase contrast-enhanced helical CT. AJR. 1999;172:1555–1559. doi: 10.2214/ajr.172.6.10350288.
    1. Sugiyama M., Katsura M., Yamamoto K., Nouchi W., Abe N., Hatano N., Atomi Y. Pancreatic metastasis from renal cell carcinoma causing massive gastrointestinal bleeding in von Hippel-Lindau disease. Hepatogastroenterology. 1999;46:1199–1201.
    1. Yavaşçaoğlu I., Korun N., Oktay B., Simsek U., Ozyurt M. Renal cell carcinoma with solitary synchronous pancreaticoduodenal and metachronous periprostatic metastases: Report of a case. Surg. Today. 1999;29:364–366. doi: 10.1007/BF02483065.
    1. Fricke P., Schulz H.U., Buhtz B., Lippert H. Multiple metachrone Metastasen eines Nierenzellkarzinoms im Pankreas. Fallbeschreibung und Literaturübersicht. Chirurg. 2000;71:575–579. doi: 10.1007/s001040050860.
    1. Ghavamian R., Klein K.A., Stephens D.H., Welch T.J., LeRoy A.J., Richardson R.L., Burch P.A., Zincke H. Renal cell carcinoma metastatic to the pancreas: Clinical and radiological features. Mayo Clin. Proc. 2000;75:581–585. doi: 10.4065/75.6.581.
    1. Kassabian A., Stein J., Jabbour N., Parsa K., Skinner D., Parekh D., Cosenza C., Selby R. Renal cell carcinoma metastatic to the pancreas: A single institution series and review of the literature. Urology. 2000;56:211–215. doi: 10.1016/S0090-4295(00)00639-7.
    1. Le Borgne J., Partensky C., Glemain P., Dupas B., de Kerviller B. Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors. Hepatogastroenterology. 2000;47:540–544.
    1. Mehta N., Volpe C., Haley T., Balos L., Bradley E.L., Doerr R.J. Pancreaticoduodenectomy for metastatic renal cell carcinoma: Report of a case. Surg. Today. 2000;30:94–97. doi: 10.1007/PL00010057.
    1. Thompson L.D., Heffess C.S. Renal cell carcinoma to the pancreas in surgical pathology material. Cancer. 2000;89:1076–1089. doi: 10.1002/1097-0142(20000901)89:5<1076::AID-CNCR17>;2-M.
    1. Espinoza R., Rossi R., Rossi R., Rosenberg H. Metachronous pancreatic metastasis of a renal cell carcinoma: 3 new cases. Rev. Med. Chil. 2001;129:86–90.
    1. Faure J.P., Tuech J.J., Richer J.P., Pessaux P., Arnaud J.P., Carretier M. Pancreatic metastasis of renal cell carcinoma: Presentation, treatment and survival. J. Urol. 2001;165:20–22. doi: 10.1097/00005392-200101000-00005.
    1. Marusch F., Koch A., Dietrich F., Hoschke B., Gastinger I. A singular late metastasis of renal cell carcinoma inside the pancreas. An uncommon pancreatic tumor. Zentralbl. Chir. 2001;126:391–395. doi: 10.1055/s-2001-14748.
    1. Ruibal Moldes M., Quintana de la Rosa J., Farina Perez L., Tardaguila F., Ortiz Rey J., Zungri Telo E. Late pancreatic metastasis from renal carcinoma. Actas Urol. Esp. 2001;25:122–124. doi: 10.1016/S0210-4806(01)72585-5.
    1. Scatarige J., Horton K., Sheth S., Fishman E. Pancreatic parenchymal metastases: Observations on helical CT. Am. J. Roentenol. 2001;176:695–699. doi: 10.2214/ajr.176.3.1760695.
    1. Sohn T.A., Yeo C.J., Cameron J.L., Nakeeb A., Lillemoe K.D. Renal cell carcinoma metastatic to the pancreas: Results of surgical management. J. Gastrointest. Surg. 2001;5:346–351. doi: 10.1016/S1091-255X(01)80060-3.
    1. Tada T., Kobayashi G., Noda Y., Kimura K., Ito K., Fujita N. A resected case with multiple pancreatic metastasis of renal cell carcinoma. Nippon Shokakibyo Gakkai Zasshi. 2001;98:1368–1373.
    1. Béchade D., Palazzo I., Desramé J., Duvic C., Hérody M., Didelot F., Coutant G., Algayres J. Pancreatic metastasis of renal carcinoma: Report of three cases. Rev. Med. Interne. 2002;23:862–866. doi: 10.1016/S0248-8663(02)00693-8.
    1. Chao K., Hurley J., Neerhut G., Kiroff G. Multiple pancreatic metastases from renal cell carcinoma. ANZ J. Surg. 2002;72:310–312. doi: 10.1046/j.1445-2197.2002.02384.x.
    1. Chou Y., Chiou H., Hong T., Tiu C., Chiou S., Su C., Tsay S. Solitary metastasis from renal cell carcinoma presenting as diffuse pancreatic enlargement. J. Clin. Ultrasound. 2002;30:499–502. doi: 10.1002/jcu.10104.
    1. Eloubeidi M.A., Jhala D., Chhieng D.C., Jhala N., Eltoum I., Wilcox C.M. Multiple late asymptomatic pancreatic metastases from renal cell carcinoma: Diagnosis by endoscopic ultrasound-guided fine needle aspiration biopsy with immunocytochemical correlation. Dig. Dis. Sci. 2002;47:1839–1842. doi: 10.1023/A:1016413132470.
    1. Hiotis S., Klimstra D., Conlon K., Brennan M. Results after pancreatic resection for metastatic lesions. Ann. Surg. Oncol. 2002;9:675–679. doi: 10.1007/BF02574484.
    1. Lisii D., Gaimant A., Sautereau D., Paraf F., Maubon A. Duodenal bleeding revealing a renal cell carcinoma. Gastroenterol. Clin. Biol. 2002;26:1044–1046.
    1. Peschaud F., Cheynel N., Hagry O., Tremeaux J.C., Rat P., Favre J.P. Surgical treatment of pancreatic metastases from renal carcinoma. Ann. Chir. 2002;127:527–531. doi: 10.1016/S0003-3944(02)00839-8.
    1. Roviello F., Nastri G., Hako L., Marrelli D., De Stefano A., Cioppa T., Pinto E. Pancreatic metastasis from clear renal cell carcinoma: A clinical case. Chir. Ital. 2002;54:873–877.
    1. Yachida S., Fukushima N., Kanai Y., Nimura S., Shimada K., Yamamoto J., Sakamoto M. Pancreatic metastasis from renal cell carcinoma extending into the main pancreatic duct: A case report. Jpn. J. Clin. Oncol. 2002;32:315–317. doi: 10.1093/jjco/hyf066.
    1. Bassi C., Butturini G., Falconi M., Sargenti W., Mantovavi W., Pederzoli P. High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br. J. Surg. 2003;90:555–559. doi: 10.1002/bjs.4072.
    1. Giulini S., Portolani N., Bonardelli S., Baiocchi G., Zampatti N., Coniglio A., Baronchelli C. Distal pancreatic resection with splenic preservation for metastasis of renal carcinoma diagnosed 24 years later from the nephrectomy. Ann. Ital. Chir. 2003;74:93–96.
    1. Hernandez D.J., Kavoussi L.R., Ellison L. Laparoscopic distal pancreatectomy for metastatic renal cell carcinoma. Urology. 2003;62:551. doi: 10.1016/S0090-4295(03)00403-5.
    1. Law C.H., Wei A.C., Hanna S.S., Al-Zahrani M., Taylor B.R., Greig B., Langer B., Gallinger S. Pancreatic resection for metastatic renal cell carcinoma: Presentation, treatment and outcome. Ann. Surg. Oncol. 2003;10:922–926. doi: 10.1245/ASO.2003.02.003.
    1. Nakagohri T., Konishi M., Inoue K., Nakamura T., Kinoshita T. Partial pancreatic head resection for pancreatis metastasis from renal cell carcinoma. Hepatogastroenterology. 2003;50:2236–2238.
    1. Pecchi A., Cesinaro A., Torricelli P. Solitary pancreatic metastasis from renal cell carcinoma. A case report. Radiol. Med. 2003;105:386–390.
    1. Uemura T., Kurita A., Nishimura R., Ishizaki M., Takashima S. Solitary pancreatic metastasis from renal cell carcinoma concomitant with early gastric cancer 17 years after nephrectomy. Report of a case. Surg. Today. 2003;33:395–398. doi: 10.1007/s005950300090.
    1. Zacharoulis D., Asopa V., Karvounis E., Williamson R.C. Resection of renal metastases to the pancreas: A surgical challenge. HPB. 2003;5:137–141. doi: 10.1080/13651820310000677.
    1. Kijvikai K., Ratana-olarn K. Solitary pancreatic metastasis from renal cell carcinoma 14 years after nephrectomy: A case report. J. Med. Assoc. Thai. 2004;87:1123–1126.
    1. Kobayashi A., Yamaguchi T., Ishihara T., Tadenuma H., Nakamura K., Ohshimi T., Sakaue N., Baba T., Yoshikawa M., Saisho H. Spontaneous rupture of pancreatic metastasis from renal cell carcinoma. Jpn. J. Clin. Oncol. 2004;34:696–699. doi: 10.1093/jjco/hyh127.
    1. Kornprat P., Bacher H., Hauser H., Cerwenka H., El-Shabrawi A., Lackner C., Mischinger H.J. Renal cell carcinoma with metastasis to the pancreas: A case report and literature review. Eur. Surg. 2004;36:381–384. doi: 10.1007/s10353-004-0112-5.
    1. Moussa A., Mitry E., Hammel P., Sauvanet A., Nassif T., Palazzo L. Pancreatic metastasis: A multicentric study of 22 patients. Gastroenterol. Clin. Biol. 2004;28:872–876. doi: 10.1016/s0399-8320(04)95151-2.
    1. Paparel P., Cotton F., Voiglio E., Decaussin M., Isaac S., Caillot J.L. A case of late pancreatic metastasis from renal cell carcinoma. Prog. Urol. 2004;14:403–405.
    1. Ninan S., Jain P.K., Paul A., Menon K.V. Synchronous pancreatic metastases from asymptomatic renal cell carcinoma. JOP. 2005;6:26–28.
    1. Pekmezci S., Sarıbeyoglu K., Kahya A.S., Kapan M., Durgun V. Pancreatic renal cell carcinoma metastasis presenting with upper gastrointestinal bleeding. Surgery. 2005;137:386–387. doi: 10.1016/j.surg.2003.10.020.
    1. Sotiropoulos G.C., Lang H., Liu C., Brokalaki E.I., Molmenti E., Broelsch C.E. Surgical treatment of pancreatic metastases of renal cell carcinoma. JOP. 2005;6:339–343.
    1. Wente M.N., Kleef J., Esposito I., Hartel M., Müller M.W., Fröhlich E., Büchler M.W., Friess H. Renal cancer cell metastasis into the pancreas: A single-center experience and overview of the literature. Pancreas. 2005;30:218–222. doi: 10.1097/01.mpa.0000153337.58105.47.
    1. Crippa S., Angelini C., Mussi C., Bonardi C., Romano F., Sartori P., Uggeri F., Bovo G. Surgical treatment of metastatic tumors to the pancreas: A single center experience and review of the literature. World J. Surg. 2006;30:1536–1542. doi: 10.1007/s00268-005-0464-4.
    1. Köhler K., Haroske G., Ludwig K. Management of pancreatic metastases from renal cell carcinoma. Report of five cases. Zentralbl. Chir. 2006;131:425–428. doi: 10.1055/s-2006-949531.
    1. Shrikhande S.V., Büchler P., Esposito I., Loos M., Büchler M.W., Friess H. Splenic and portal vein thrombosis in pancreatic metastasis from renal cell carcinoma. World. J. Surg. Oncol. 2006;4:25. doi: 10.1186/1477-7819-4-25.
    1. Akatsu T., Shimazu M., Aiura K., Ito Y., Shinoda M., Kawachi S., Tanabe M., Ueda M., Kitajima M., Kitagawa Y. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma. Hepatogastroenterology. 2007;54:1836–1840.
    1. Eidt S., Jergas M., Schmidt R., Siedek M. Metastasis to the pancreas—An indication for pancreatic resection? Langenbecks Arch. Surg. 2007;392:539–542. doi: 10.1007/s00423-007-0148-7.
    1. Goto T., Dohmen T., Yoneyama K. Pancreatic metastasis from renal cell carcinoma. Clin. Gastroenterol. Hepatol. 2007;5:A26. doi: 10.1016/j.cgh.2007.04.030.
    1. Karimi K.M., McFadden D.W. Pancreatic resection for metastatic renal cell carcinoma to the pancreas. Am. Surg. 2007;73:58–60. doi: 10.1177/000313480707301117.
    1. Maeda H., Okabayashi T., Nishimori I., Kobayashi M., Sugimoto T., Kohsaki T., Onishi S., Hanazaki K. Duodenum-preserving pancreatic head resection for pancreatic metastasis from renal cell carcinoma: A case report. Langenbecks Arch. Surg. 2007;392:649–652. doi: 10.1007/s00423-007-0204-3.
    1. Varker K.A., Muscarella P., Wall K., Ellison C., Bloomston M. Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. World. J. Surg. Oncol. 2007;5:145. doi: 10.1186/1477-7819-5-145.
    1. Aimoto T., Uchida E., Yamahatsu K., Yoshida H., Hiroi M., Tajiri T. Surgical treatment for isolated multiple pancreatic metastases from renal cell carcinoma: Report of a case. J. Nippon Med. Sch. 2008;75:221–224. doi: 10.1272/jnms.75.221.
    1. Bahra M., Jacob D., Langrehr J.M., Glanemann M., Schumacher G., Lopez-Hänninen E., Neuhaus P. Metastasen im Pankreas. Wann ist eine Resektion sinnvoll? Chirurg. 2008;79:241–248. doi: 10.1007/s00104-007-1390-9.
    1. Kawakami H., Kuwatani M., Yamato H., Shinada K., Hirano S., Kondo S., Yonemori A., Matsuno Y., Asaka M. Pancreatic metastasis from renal cell carcinoma with intraportal tumor thrombus. Inter. Med. 2008;47:1967–1970. doi: 10.2169/internalmedicine.47.1418.
    1. Matsutani T., Sasajima K., Miyamoto M., Yokoyama T., Maruyama H., Yanagi K., Matsuda A., Kashiwabara M., Suzuki S., Tajiri T. Resection of pancreatic metastasis from renal cell carcinoma and an early gastric cancer. J. Nippon Med. Sch. 2008;75:41–45. doi: 10.1272/jnms.75.41.
    1. Koide N., Yokoyama Y., Oda K., Nishio H., Ebata T., Abe T., Igami T., Nimura Y., Nagino M. Pancreatic metastasis from renal cell carcinoma. Results of the surgical management and pathologic findings. Pancreas. 2008;37:104–107. doi: 10.1097/MPA.0b013e3181619a2f.
    1. Schauer M., Vogelsang H., Siewert J.R. Pancreatic resection for metastatic renal cell carcinoma: A single center experience and review of the literature. Anticancer Res. 2008;28:361–366.
    1. Shukla R.C., Pathak R., Senthil S. Pancreatic metastases of renal cell carcinoma—Case report. Nepal. Med. Coll. J. 2008;10:275–277.
    1. Tuech J., Lefebure R., Bridoux V., Albouy B., Lermite E., Le Pessot F., Le Blanc-Louvry I., Michot F. Combined resection of the pancreas and inferior vena cava for pancreatic metastasis from renal cell carcinoma. J. Gastrointest. Surg. 2008;12:612–615. doi: 10.1007/s11605-007-0295-8.
    1. Zerbi A., Ortolano E., Balzano G., Borri A., Beneduce A.A., Di Carlo V. Pancreatic metastasis from renal cell carcinoma: Which patients benefit from surgical resection? Ann. Surg. Oncol. 2008;15:1161–1168. doi: 10.1245/s10434-007-9782-0.
    1. Deguchi Y., Shimada K., Nara S., Esaki M., Sakamoto Y., Kosuge T., Hiraoka N. Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: Report of a case. Surg. Today. 2009;39:1086–1090. doi: 10.1007/s00595-008-3998-x.
    1. Machado N.O., Chopra P. Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome. JOP. 2009;10:413–418.
    1. Tanis P.J., van der Gaag N.A., Busch O.R., van Gulik T.M., Gouma D.J. Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br. J. Surg. 2009;96:579–592. doi: 10.1002/bjs.6606.
    1. Volk A., Kersting S., Konopke R., Dobrowolski F., Franzen S., Ockert D., Grützmann R., Saeger H.D., Bergert H. Surgical therapy of intrapancreatic metastasis from renal cell carcinoma. Pancreatology. 2009;9:392–397. doi: 10.1159/000181174.
    1. Akashi Y., Saiura A., Kishi Y., Koga R., Morimura R., Yoshioka R., Yamamoto J., Yamaguchi T. Outcome after surgical resection of isolated metastases to the pancreas. Hepatogastroenterology. 2010;57:1549–1552.
    1. Barbaros U., Sümer A., Demirel T., Karakullukçu N., Batman B., Içsan Y., Sariçam G., Serin K., Loh W.L., Dinççag A., et al. Single incision laparoscopic pancreas resection for pancreatic metastasis of renal cell carcinoma. JSLS. 2010;14:566–570. doi: 10.4293/108680810X12924466008448.
    1. Hijioka S., Hifumi M., Mekky M., Takekuma Y., Kawaguchi T., Yokomizo H., Sato T. Total pancreatectomy for metastatic renal cell carcinoma with marked extension into the main pancreatic duct. Inter. Med. 2010;49:557–562. doi: 10.2169/internalmedicine.49.2943.
    1. Kitasato A., Tajima Y., Kuroki T., Tsutsumi R., Tsuneoka N., Adachi T., Mishima T., Kanematsu T. Limited pancreatectomy for metastatic pancreatic tumors from renal cell carcinoma. Hepatogastroenterology. 2010;57:354–357.
    1. Masetti M., Zanini N., Martuzzi F., Fabbri C., Mastrangelo L., Landolfo G., Fornelli A., Burzi M., Vezzelli E., Jovine E. Analysis of prognostic factors in metastatic tumors of the pancreas: A single-center experience and review of the literature. Pancreas. 2010;39:135–143. doi: 10.1097/MPA.0b013e3181bae9b3.
    1. Szabó K.G., Szentkereszty Z., Tóth L.A., Damjanovich L., Sápy P. Distal pancreas resection for metastasis of clear cell renal cancer. Magy. Seb. 2010;63:161–163. doi: 10.1556/maseb.63.2010.4.3.
    1. Vujcic T., Brahm J., Buckel E., Ibarra A., Vial M.T., Fernández M. Pancreatic metastasis from renal cell carcinoma: A case report. Rev. Med. Chile. 2010;138:738–741. doi: 10.4067/s0034-98872010000600011.
    1. Yokonishi T., Ito Y., Osaka K., Komiya A., Kobayashi K., Sakai N., Noguchi S., Kishi H., Satomi Y., Mogaki M., et al. Pancreatic metastasis from renal cell carcinoma 25 years after radical nephrectomy. Hinyokika Kiyo. 2010;56:629–633.
    1. D’Ambra M., Ricci C., Casadei R., Minni F. Pancreatic metastasis from renal cell carcinoma. Urologia. 2011;78:5–8. doi: 10.5301/RU.2011.8834.
    1. Irigoin R.R., Entrenas A.O., Urbano V.A., Marin J.G., Salgado T.P., Zabal J.M., Adan N.G. Solitary pancreatic metastasis from renal carcinoma. Gastroenterol. Hepatol. 2011;34:624–628. doi: 10.1016/j.gastrohep.2011.06.002.
    1. Masago T., Watanabe T., Nemoto R. Small renal cell carcinoma with pancreas metastasis: A case report. Hinyokika Kiyo. 2011;57:607–610.
    1. Miyao N., Naito S., Ozono S., Shinohara N., Masumori N., Igarashi T., Nakao M., Tsushima T., Senga Y., Horie S., et al. Late recurrence of renal cell carcinoma: Retrospective and collaborative study of the Japanese society of renal cancer. Urology. 2011;77:379–384. doi: 10.1016/j.urology.2010.07.462.
    1. Thadani A., Pais S., Savino J. Metastasis of renal cell carcinoma to the pancreas 13 years postnephrectomy. Gastroenterol. Hepatol. 2011;7:697–699.
    1. Watanabe T., Morinaga S., Numata M., Mikayama Y., Tamura S., Tamagawa H., Yamamoto N., Shiozawa M., Ohkawa S., Kameda Y., et al. Pancreatic resection for metastatic tumors to the pancreas. Gan Kagaku Ryoho. 2011;38:2068–2070.
    1. You D.D., Choi D.W., Choi S.H., Heo J.S., Kim W.S., Ho C.Y., Lee H.G. Surgical resection of metastasis to the pancreas. J. Korean Surg. Soc. 2011;80:278–282. doi: 10.4174/jkss.2011.80.4.278.
    1. Çomunoğlu C., Altaca G., Demiralay E., Moray G. Multiple metastatic renal cell carcinoma isolated to pancreas. Malays. J. Pathol. 2012;34:63–66.
    1. Firek P., Richter S., Jaekel J., Brehmer B., Heidenreich A. Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors. Urologe. 2012;51:398–402. doi: 10.1007/s00120-011-2762-9.
    1. Gardini A., Morgagni P., Milandri C., Riccobon A., Ridolfi R., La Barba G., Saragoni L., Amadori D., Garcea D. Pancreatic resection for metastases from renal cancer: Long term outcome after surgery and immunotherapy approach—Single center experience. Hepatogastroenterology. 2012;59:687–690. doi: 10.5754/hge12185.
    1. Katsourakis A., Noussios G., Hadjis I., Alatsakis M., Chatzitheoklitos E. Late solitary pancreatic metastasis from renal cell carcinoma: A case report. Case Rep. Med. 2012;2012:464808. doi: 10.1155/2012/464808.
    1. Yazbek T., Gayet B. The place of enucleation and enucleo-resection in the treatment of pancreatic metastasis of renal cell carcinoma. JOP. 2012;13:433–438. doi: 10.6092/1590-8577/863.
    1. Zygulska A.L., Wójcik A., Richter P., Krzesiwo K. Renal carcinoma metachronous metastases to the gall-bladder and pancreas—Case report. Pol. Przegl. Chir. 2012;84:313–316. doi: 10.2478/v10035-012-0052-x.
    1. Hata T., Sakata N., Aoki T., Yoshida H., Kanno A., Fujishima F., Motoi F., Masamune A., Shimosegawa T., Unno M. Repeated pancreatectomy for metachronous duodenal and pancreatic metastases of renal cell carcinoma. Case Rep. Gastroenterol. 2013;7:442–448. doi: 10.1159/000355884.
    1. Hoshino Y., Shinozaki H., Kimura Y., Masugi Y., Ito H., Terauchi T., Kimatam M., Furukawa J., Kobayashi K., Ogata Y. Pancreatic metastases from renal cell carcinoma: A case report and literature review of the clinical and radiological characteristics. World J. Surg. Oncol. 2013;11:289. doi: 10.1186/1477-7819-11-289.
    1. Kapoor R., Kumar R., Dey P., Mittal B.R. A late recurrence of renal cell carcinoma as pancreatic metastases: A rare disease. BMJ Case Rep. 2013;2013:bcr2013009314. doi: 10.1136/bcr-2013-009314.
    1. Markinez I., Jiménez R., Ruiz I., Villarreal E., Lizarazu A., Borda N., Arteaga X., Medrano M.Á., Guisasola E., Beguiristain A., et al. Pancreatic metastases due to renal carcinoma. Our cases and a literature review. Cir. Esp. 2013;91:90–95. doi: 10.1016/j.ciresp.2012.07.007.
    1. Mqirage M., Zabala Egurrola J., Rodríguez J., Pertusa Peña C. Métastase pancréatique métachrone du cancer du rein: À propos d’un cas. Can. Urol. Assoc. J. 2013;7:e460–e461. doi: 10.5489/cuaj.1388.
    1. Simtniece Z., Kirsakmens G., Strumfa I., Vanaga A., Gardovskis J. Delayed pancreatic metastasis of renal clear cell carcinoma. Acta Chir. Latv. 2013;13:79–80. doi: 10.2478/chilat-2014-0016.
    1. Yabe N., Murai S., Shimizu H., Kitasato K., Yoshikawa T., Oto I., Nakadai J., Hasegawa H., Kitagawa Y. A case of pancreatic metastasis from renal cell carcinoma 27 years after nephrectomy. Gan Kagaku Ryoho. 2013;40:1897–1899.
    1. Yoshikawa Y., Murakami M., Shimizu J., Yasuyama A., Watase C., Kubota M., Miyake Y., Matsuura Y., Kim H.M., Hirota M., et al. A case of partial pancreatectomy for recurrent metastatic renal cell carcinoma in the remnant pancreas after subtotal stomach-preserving pancreaticoduodenectomy. Gan Kagaku Ryoho. 2013;40:1900–1902.
    1. Untsch Y., Keira Y., Imamura M., Ito T., Nobuoka T., Mizuguchi T., Masumori N., Hasegawa T., Hirata K. Histopathological aspects of pancreatic metastases in renal cell carcinoma: Does the mode of invasion permit limited resections? Pancreat. Disord. Ther. 2014;4:2. doi: 10.4172/2165-7092.1000136.
    1. Lauro S., Onesti E.C., Righini R., Carbonetti F., Cremona A., Marchetti P. A synchronous pancreatic metastasis from renal clear cell carcinoma, with unusual CT characteristics, completely regressed after therapy with sunitinib. Case Rep. Med. 2014;2014:473431. doi: 10.1155/2014/473431.
    1. Matsuki M., Ichihara K., Matsuda Y., Taguchi K. Clinical features of six patients with pancreas metastasis from renal cell carcinoma. Hinyokika Kiyo. 2014;60:105–108.
    1. Macrì A., Fleres F., Putortì A., Lentini M., Ascenti G., Mastrojeni C. Relapsed metachronous pancreatic metastasis from renal cell carcinoma (RCC): Report of a case and review of literature. Ann. Ital. Chir. 2014;85:S2239253X1402283X.
    1. Minni F., Casadei R., Perence B., Greco V.M., Marrano N., Margiotta A., Marrano D. Pancreatic metastases: Observations of three cases and review of the literature. Pancreatology. 2014;4:509–520. doi: 10.1159/000080248.
    1. Moletta L., Milanetto A.C., Vincenzi V., Alaggio R., Pedrazzoli S., Pasquali C. Pancreatic secondary lesions from renal cell carcinoma. World J. Surg. 2014;38:3002–3006. doi: 10.1007/s00268-014-2672-2.
    1. Schwarz L., Sauvanet A., Regenet N., Mabrut J.Y., Gigot J.F., Housseau E., Millat B., Ouaissi M., Gayet B., Fuks D., et al. Long-term survival after pancreatic resection for renal cell carcinoma metastasis. Ann. Surg. Oncol. 2014;21:4007–4013. doi: 10.1245/s10434-014-3821-4.
    1. Takeshi A., Mitsuhiro I., Hiromitsu A., Naoyuki Y., Taiichiro S., Hiroki S., Takeaki K., Tatsuya S., Futoshi O., Hiroharo S., et al. Middle segment-preserving pancreatectomy for recurrent metastasis of renal cell carcinoma after pancreatoduodenenctomy: A case report. Case Rep. Surg. 2014;2014:648678. doi: 10.1155/2014/648678.
    1. Tosoian J.J., Cameron J.L., Allaf M.E., Hruban R.H., Nahime C.B., Pawlik T.M., Pierorazio P.M., Reddy S., Wolfgang C.L. Resection of isolated renal cell carcinoma metastases of the pancreas: Outcomes from the Johns Hopkins Hospital. J. Gastrointest. Surg. 2014;18:542–548. doi: 10.1007/s11605-013-2278-2.
    1. Benhaim R., Oussoultzoglou E., Saeedi Y., Mouracade P., Bachellier P., Lang H. Pancreatic metastasis from clear cell renal cell carcinoma: Outcome of an aggressive approach. Urology. 2015;85:135–140. doi: 10.1016/j.urology.2014.09.034.
    1. Chang Y., Liaw C., Chuang C. The role of surgery in renal cell carcinoma with pancreatic metastasis. Biomed. J. 2015;38:173–176. doi: 10.4103/2319-4170.137771.
    1. Gajendra S., Sachdev R., Mohapatra I., Goel R., Goel S. Metastatic renal cell carcinoma: An unusual cause of bleeding pancreatic mass. J. Clin. Diagn. Res. 2015;9:ED15–ED17. doi: 10.7860/JCDR/2015/14350.6519.
    1. Kitade H., Yanagida H., Yamada M., Matsuura T., Yoshioka K., Satoi S., Matsui Y., Kon M. Pylorus-preserving total pancreatectomy for metastatic renal cell carcinoma: A case report. J. Med. Case Rep. 2015;9:212. doi: 10.1186/s13256-015-0654-0.
    1. Kusnierz K., Mrowiec S., Lampe P. Results of surgical management of renal cell carcinoma metastatic to the pancreas. Contemp. Oncol. 2015;19:54–59. doi: 10.5114/wo.2014.45306.
    1. Santoni M., Conti A., Partelli S., Porta C., Sternberg C.N., Procopio G., Bracarda S., Basso U., De Giorgi U., Derosa L., et al. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann. Surg. Oncol. 2015;22:2094–2100. doi: 10.1245/s10434-014-4256-7.
    1. Yuasa T., Inoshita N., Saiura A., Yamamoto S., Urakami S., Masusa H., Fujii Y., Fukui I., Ishikawa Y., Yonese J. Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer. 2015;15:46. doi: 10.1186/s12885-015-1050-2.
    1. Baltazar M.P., Meirinha A., Joao R., Pina M.J., Pinheiro H., Fernandes F., Falcao G., Forte J.P., Carvalho A.M., Vigia E., et al. Obstructive jaundice as a rare presentation of metastatic renal cell carcinoma—Clinical case and literature review. Acta Urol. Port. 2016;33:68–73. doi: 10.1016/j.acup.2016.04.002.
    1. Boussios S., Zerdes J., Batsi O., Papakostas P., Seraj E., Pentheroudakis G., Glantzounis G. Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence. Int. J. Surg. Case Rep. 2016;27:198–201. doi: 10.1016/j.ijscr.2016.08.039.
    1. Dong J., Cong L., Zhang T.P., Zhao Y.P. Pancreatic metastasis of renal cell carcinoma. Hepatobiliary Pancreat. Dis. Int. 2016;15:30–38. doi: 10.1016/S1499-3872(16)60052-8.
    1. Fikatas P., Klein F., Andreou A., Schmuck R.B., Pratschke J., Bahra M. Long-term survival after surgical treatment of renal cell carcinoma metastasis within the pancreas. Anticancer Res. 2016;36:4273–4278.
    1. Koga C., Murakami M., Shimizu J., Matsumara T., Kameda C., Kawabata R., Oda N., Hirota M., Yoshikawa M., Morishima H., et al. A case of multiple pancreatic metastases from renal cell carcinoma diagnosed using EUS-FNA. Gan Kagaku Ryoho. 2016;43:2356–2358.
    1. Miura T., Nakamura N., Ogawa K., Watanabe Y., Yonekura K., Sanada T., Kuwabara H., Goseki N. Resection of pancreatic metastasis from renal cell carcinoma 21 years after nephrectomy. Gan Kagaku Ryoho. 2016;43:2187–2189.
    1. Nihei K., Sakamoto K., Suzuki S., Mishina T., Otaki M. A case of pancreatic metastasis of renal cell carcinoma. Gan Kagaku Ryoho. 2016;43:2274–2276.
    1. Rückert F., Distler M., Ollmann D., Lietzmann A., Birgin E., Teoule P., Grützmann R., Wilhelm T.J. Retrospective analysis of survival after resection of pancreatic renal cell carcinoma metastases. Int. J. Surg. 2016;26:64–68. doi: 10.1016/j.ijsu.2015.12.003.
    1. Chatzizacharias N.A., Rosich-Medina A., Dajani K., Harper S., Huguet E., Liau S.S., Praseedom R.K., Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J. Gastrointest. Oncol. 2017;15:70–77. doi: 10.4251/wjgo.v9.i2.70.
    1. Garcia-Major Fernandez R.L., Fernandez-Gonzales M. Diagnosis and treatment of isolated metastases from renal clear cell carcinoma: Report of a case and review of literature. Cir. Cir. 2017;85:436–439. doi: 10.1016/j.circir.2016.05.007.
    1. Ko S., Yun S., Kim S., Kim T., Seo H. Pancreatic resection for renal cell carcinoma metastasis: A case review. Ann. Hepatobiliary Pancreat. Surg. 2017;21:176–179. doi: 10.14701/ahbps.2017.21.3.176.
    1. Lee S.R., Gemenetzis G., Cooper M., Javed A.A., Cameron J.L., Wolfgang C.L., Eckhauser F.E., He J., Weiss M.J. Long-term outcomes of 98 surgically resected metastatic tumors in the pancreas. Ann. Surg. Oncol. 2017;24:801–807. doi: 10.1245/s10434-016-5619-z.
    1. Shatveryan G.A., Chardarov N.K., Bagmet N.N., Ratnikova N.P., Bedzhanyan A.L., Petrenko K.N., Polishchuk L.O., Karagyozyan G.A. Isolated pancreatic metastases of renal cell carcinoma. Khirurgiia. 2017;12:36–40. doi: 10.17116/hirurgia20171236-40.
    1. Zianne M., Takahashi N., Tsujibata A., Miwa K., Goto Y., Matano Y. Asymptomatic pancreatic metastasis from renal cell carcinoma diagnosed 21 years after nephrectomy. Case Rep. Gastrointest. Med. 2017;2017:8765264. doi: 10.1155/2017/8765264.
    1. Boni A., Cochetti G., Ascani S., Del Zingaro M., Quadrini F., Paladini A., Cocca D., Mearini E. Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: Case report and review of the literature. BMC Surg. 2018;18:40. doi: 10.1186/s12893-018-0371-x.
    1. Kling S.M., Tannouri S., Jiang W., Yeo C.J. Pancreatic mass in a patient with a history of resected renal cell carcinoma and resected adenocarcinoma of the ampulla of Vater: A case report. J. Pancreat. Cancer. 2018;4:41–44. doi: 10.1089/pancan.2018.0001.
    1. Limaiem F., Bouraoui S. Metastasis of renal cell carcinoma to the pancreas 11 years postnephrectomy. Pan. Afr. Med. J. 2018;30:53. doi: 10.11604/pamj.2018.30.53.15355.
    1. Nogueira M., Dias S.C., Silva A.C., Pintob J., Machado J. Solitary pancreatic renal cell carcinoma metastasis. Autops. Case Rep. 2018;23:8. doi: 10.4322/acr.2018.023.
    1. Yamashita H., Toyama H., Terai S., Mukubou H., Shirakawa S., Ishida J., Asakura Y., Shimizu T., Lee D., Tanaka M., et al. A patient with multiple pancreatic metastases undergoing total pancreatectomy 18 years after renal cell carcinoma resection. Gan Kagaku Ryoho. 2018;45:2214–2216.
    1. Yu Q., Kan F., Ma Z., Wang T., Lin G., Chen B., Zhao W. CT Diagnosis for metastasis of clear cell renal cell carcinoma to the pancreas: Three case reports. Medicine. 2018;97:e13200. doi: 10.1097/MD.0000000000013200.
    1. Ayari Y., Ben Rhouma S., Boussaffa H., Chelly B., Hamza K., Sellami A., Jrad M., Nouira Y. Metachronous isolated locally advanced pancreatic metastasis from chromophobe renal cell carcinoma. Int. J. Surg. Case Rep. 2019;60:196–199. doi: 10.1016/j.ijscr.2019.05.046.
    1. Brozetti S., Sterpetti A.V. Unexpected prolonged survival after extended and emergent resection of pancreatic metastases from renal cell carcinoma. J. Gastrointest. Cancer. 2019;50:1055–1058. doi: 10.1007/s12029-019-00209-w.
    1. Chon H.K., Choi K.H. Late metachronous isolated pancreatic metastasis from renal cell carcinoma mimicking a pancreatic neuroendocrine tumor. Turk. J. Gastroenterol. 2019;30:489–491. doi: 10.5152/tjg.2018.18464.
    1. Geramizadeh B., Kashkooe A., Nikeghbalian S., Malek-Hosseini S. Metastatic tumors to the pancreas, a single center study. Arch. Iran. Med. 2019;22:50–52.
    1. Glinka J., Sanchez Claria R., Ardiles V., de Santibañes E., Pekolj J., de Santibañes M., Mazza O. The pancreas as a target of metastasis from renal cell carcinoma: Results of surgical treatment in a single institution. Ann. Hepatobiliary Pancreat. Surg. 2019;23:240–244. doi: 10.14701/ahbps.2019.23.3.240.
    1. Huang Q., Zhou H., Liu C., Jin K., Fan K., Cheng H., Fan Z., Yang C., Liu L., Long J., et al. Surgical resection for metastatic tumors in the pancreas: A single-center experience and systematic review. Ann. Surg. Oncol. 2019;26:1649–1656. doi: 10.1245/s10434-019-07258-2.
    1. Jo S., Yang I.S., Song S. Surgery for metastatic renal cell carcinoma in the pancreatic head: A case report and literature review. Ann. Hepatobiliary Pancreat. Surg. 2019;23:91–95. doi: 10.14701/ahbps.2019.23.1.91.
    1. Ma Y., Yang J., Qin K., Zhou Y., Ying X., Yuan F., Shi M., Jin J., Wang D., Gu J., et al. Resection of pancreatic metastatic renal cell carcinoma: Experience and long-term survival outcome from a large center in China. Int. J. Clin. Oncol. 2019;24:686–693. doi: 10.1007/s10147-019-01399-w.
    1. Patyutko Y.I., Kotelnikov A.G., Kriger A.G., Prodkuryakov I.S., Galkin G.V., Polyakov A.N., Fainstein I.A. Metastatic renal cell carcinoma in the pancreas: Experience of surgical treatment. Khirurgiia. 2019;9:25–31. doi: 10.17116/hirurgia201909125.
    1. Teranishi R., Hatanaka N., Hara S., Takayama K., Shimura Y., Ohashi T., Osawa H., Sakai K., Yasumasa K., Noro H., et al. Two cases of pancreatectomy for pancreatic metastasis from renal cell carcinoma. Gan Kagaku Ryoho. 2019;46:561–563.
    1. Yamaguchi H., Kimura Y., Nagayama M., Imamura M., Tanaka S., Yoshida E., Fujino H., Machiki T., Miyanishi K., Mizuguchi T., et al. Central pancreatectomy in portal annular pancreas for metastatic renal cell carcinoma: A case report. World J. Surg. Oncol. 2019;17:76. doi: 10.1186/s12957-019-1622-8.
    1. Wakabayashi T., Uchida T., Oyama H., Shiozawa T., Kigawa G., Tanaka K. A case of laparoscopic distal pancreatectomy for metachronous pancreatic metastasis from renal cell carcinoma. Nihon Rinsho Geka Gakkai Zasshi. 2019;80:983–989. doi: 10.3919/jjsa.80.983.
    1. Choucair K., Parker N.A., Al-Obaidi A., Alderson J., Truong P. Solitary, late metastatic recurrence of renal cell carcinoma to the pancreas: A case report. Cureus. 2020;12:e8521. doi: 10.7759/cureus.8521.
    1. Di Franco G., Gianardi D., Palmeri M., Furbetta N., Guadagni S., Bianchini M., Bonari F., Sbrana A., Vasile E., Pollina L.E., et al. Pancreatic resections for metastases: A twenty-year experience from a tertiary care center. Eur. J. Surg. Oncol. 2020;46:825–831. doi: 10.1016/j.ejso.2019.11.514.
    1. Fahlbusch T., Luu A.M., Braumann C., Lukas C., Uhl W., Künzli B.M. Lipomatous pancreas facilitates late onset of renal cell carcinoma metastases. Acta Chir. Belg. 2020;18:314–319. doi: 10.1080/00015458.2020.1765672.
    1. Janevska V., Shumkovski A., Nikolova D., Asani L., Pandilov S., Karanfilovski V. Late onset of pancreatic metastases from renal cell carcinoma. A case report. Pril. 2020;41:57–62. doi: 10.2478/prilozi-2020-0033.
    1. Milanetto A.C., Morelli L., Di Franco G., David A., Campra D., De Paolis P., Pasquali C. A plea for surgery in pancreatic metastases from renal cell carcinoma: Indications and outcome from a multicenter surgical experience. J. Clin. Med. 2020;9:3278. doi: 10.3390/jcm9103278.
    1. Rupert K., Kural T., Skalický T., Zeithaml J., Hess O., Třeška V. Clear cell renal carcinoma metastases to the pancreas. Rozhl. Chir. 2020;99:311–315. doi: 10.33699/PIS.2020.99.7.311-315.
    1. Schammel J., Schammel C., Schammel D., Trocha S.D. Renal cell carcinoma metastasis to the pancreas: The aggressive nature of synchronous presentation—Case report and comprehensive review of the literature. SN Compr. Clin. Med. 2020 doi: 10.1007/s42399-020-00386-x.
    1. Singla N., Xie Z., Zhang Z., Gao M., Yousuf Q., Onabolu O., McKenzie T., Tcheuyap V.T., Ma Y., Choi J., et al. Pancreatic tropism of metastatic renal cell carcinoma. JCI. Insight. 2020;5:e134564. doi: 10.1172/jci.insight.134564.
    1. Zhang Z.Y., Li X.Y., Bai C.M., Zhou Y., Wu X., Yang A.M., Hua S.R. The clinicopathologic features and prognostic analysis of pancreatic metastasis from clear cell renal cell carcinoma. Zhonghua Zhong Liu Za Zhi. 2020;42:44–49. doi: 10.3760/cma.j.issn.0253-3766.2020.01.00.
    1. Bauschke A., Altendorf-Hofmann A., Deeb A.A., Kissler H., Tautenhahn H.M., Utz Settmacher U. Chirurgische Therapie von Leber und Pankreasmetastasen von Nierenzellkarzinomen. Chirurg. 2021;92:948–954. doi: 10.1007/s00104-020-01331-3.
    1. Blanco-Fernandez G., Fondevila-Campo C., Sanjuanbenito A., Fabregat-Prous J., Secanella-Medayo L., Rotellar-Sastre F., Pardo-Sanchez F., Prieto-Calvo M., Marin-Ortega H., Sanchez-Cabus S., et al. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study. Eur. J. Surg. Oncol. 2021;48:133–141. doi: 10.1016/j.ejso.2021.08.011.
    1. Ksontini F., Khrouf S., Kacem S., Hadda A., Magherbi H., Chaker Y., Ayadi M., Ben Safta Z. Pancreatic metastasis of renal cell carcinoma: A surgical indication for a disseminated disease. Case Rep. Med. 2021;2021:5579385. doi: 10.1155/2021/5579385.
    1. Malleo G., Salvia R., Maggino L., Marchegiani G., D’Angelica M., DeMatteo R., Kingham P., Pulvirenti A., Sereni E., Jarnagin W.R., et al. Long-term outcomes after surgical resection of pancreatic metastases from renal clear-cell carcinoma. Ann. Surg. Oncol. 2021;28:3100–3108. doi: 10.1245/s10434-021-09649-w.
    1. Matsui S., Ono H., Asano D., Ishikawa Y., Ueda H., Akahoshi K., Ogawa K., Kudo A., Tanaka S., Tanabe M. Pancreatic metastasis from renal cell carcinoma presenting as gastrointestinal hemorrhage: A case report. J. Surg. Case Rep. 2021;2021:rjab368. doi: 10.1093/jscr/rjab368.
    1. Piskorz Ł., Mitura K., Olejniczak W., Misiak P., Jablonski S. Atypical locations of renal cell carcinoma metastases to the pancreas and duodenum. Res. Rep. Urol. 2021;13:17–24. doi: 10.2147/RRU.S290150.
    1. Yamada Y., Sakai A., Abe S., Gonda M., Kobayashi T., Masusa A., Shiomi H., Sahirakawa S., Toyama H., Hyodo T., et al. Pancreatic metastasis of renal cell carcinoma filling into the duct of Santorini. Clin. J. Gastroenterol. 2021;14:905–909. doi: 10.1007/s12328-021-01369-8.
    1. Yamawaki M., Takano Y., Noda J., Azami T., Kobayashi T., Niiya F., Maruoka T., Nagashama M. A case of hemobilia caused by pancreatic metastasis of renal cell carcinoma treated with a covered metallic stent. Clin. J. Gastroenterol. 2021;14:905–909. doi: 10.1007/s12328-021-01532-1.
    1. McNichols D.W., Segura J.W., DeWeerd J.H. Renal cell carcinoma: Long term survival and late recurrence. J. Urol. 1981;126:17–23. doi: 10.1016/S0022-5347(17)54359-1.
    1. Dekernion J.B., Ramming K.P., Smith R.B. The natural history of metastatic renal cell carcinoma—A computer analysis. J. Urol. 1978;120:148–152. doi: 10.1016/S0022-5347(17)57082-2.
    1. DeSouza S.V., Singh R.G., Yoon H.D., Murphy R., Plank L.D., Petrov M.S. Pancreas volume in health and disease: A systematic review and meta-analysis. Expert Rev. Gastroenterol. Hepatol. 2018;12:757–766. doi: 10.1080/17474124.2018.1496015.
    1. Saitoh H., Kobayashi N., Yoshida K., Suwata J., Uchijima Y., Nakame Y. Possible metastatic routes via portocaval shunts in renal adenocarcinoma with liver metastasis. Urology. 1997;37:598–601. doi: 10.1016/0090-4295(91)80336-6.
    1. Loré J., Maddden J., Gerold F. Pre-existing portocaval shunts: A hypothesis for the bizarre metastases of some carcinomas. Cancer. 1958;11:24–27. doi: 10.1002/1097-0142(195801/02)11:1<24::AID-CNCR2820110107>;2-M.
    1. Allen-Mersh T. Significance of the site of origin of pancreatic exocrine adenocarcinoma. J. Clin. Pathol. 1982;35:544–546. doi: 10.1136/jcp.35.5.544.
    1. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;133:571–573. doi: 10.1016/S0140-6736(00)49915-0.
    1. Chambers A., Varghese H., Nadkarni K., MacDonald I., Groom A. Critical steps in hematogenous metastasis: An overview. Surg. Oncol. Clin. N. Am. 2001;10:243–255. doi: 10.1016/S1055-3207(18)30063-2.
    1. Hunter K. Host genetics and tumour metastasis. Br. J. Cancer. 2004;90:752–755. doi: 10.1038/sj.bjc.6601590.
    1. Chiang S.P., Cabrera R.M., Segall J.E. Tumor cell intravasation. Am. J. Physiol. Cell Physiol. 2016;311:C1–C14. doi: 10.1152/ajpcell.00238.2015.
    1. Chang A., Zhao L., Zhu Z., Boulanger K., Xiao H., Wakefield M.R., Bai Q., Fang Y. The past, present and future of immunotherapy for metastatic renal cell carcinoma. Anticancer Res. 2019;39:2683–2687. doi: 10.21873/anticanres.13393.
    1. Da Silva J.L., Dos Santos A., Nunes N., Lino da Silva F., Ferreira C., de Melo A.C. Cancer immunotherapy: The art of targeting the tumor immune microenvironment. Cancer Chemother. Pharmacol. 2019;84:227–240. doi: 10.1007/s00280-019-03894-3.
    1. Jonasch E. Updates to the management of kidney cancers. J. Natl. Compr. Canc. Netw. 2018;16:639–641. doi: 10.6004/jnccn.2018.0039.
    1. Flippot R., Escudier B., Albiges L. Immune checkpoint inhibitors: Toward new paradigms in renal cell carcinoma. Drugs. 2018;78:1443–1457. doi: 10.1007/s40265-018-0970-y.
    1. Rini B., Escudier B., Tomczak P., Kaprin A., Szczylik C., Hutson T.E., Michaelson M.D., Gorbunova V., Gore M.E., Rusakov I.G., et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomized phase III trial. Lancet. 2012;378:1931–1939. doi: 10.1016/S0140-6736(11)61613-9.
    1. Beck J., Bellmunt J., Escudier B. Long-term stable disease in metastatic renal cell carcinoma: Sorafenib sequenced to sunitinib and everolimus: A case study. Med. Oncol. 2011;28:1379–1383. doi: 10.1007/s12032-010-9589-x.
    1. Motzer R.J., Hutson T.E., Tomczak P., Michaelson M.D., Bukowski R.M., Oudard S., Negrier S., Szczylik C., Pili R., Bjarnason G.A., et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cancer. J. Clin. Oncol. 2009;27:3584–3590. doi: 10.1200/JCO.2008.20.1293.
    1. Gonzales H., Hagerling C., Werb Z. Roles of immune system in cancer: From tumour initiation to metastatic progression. Genes Dev. 2018;32:1267–1284. doi: 10.1101/gad.314617.118.
    1. Makhov P., Joshi S., Ghatalia P., Kutikov A., Uzzo R.G., Kolenko V.M. Resistance to systemic therapies in clear cell renal cell carcinoma: Mechanisms and management strategies. Mol. Cancer Ther. 2018;17:1355–1364. doi: 10.1158/1535-7163.MCT-17-1299.
    1. Heraudet L., Domblides C., Daste A., Lefort F., Bernhard J.C., Ravaud A., Gross-Goupil M. Safety of sunitinib in patients with renal cell carcinoma following nephrectomy. Expert. Opin. Drug. Saf. 2020;19:799–806. doi: 10.1080/14740338.2020.1774551.
    1. Rini B.I., Battle D., Figlin R.A., George D.J., Hammers H., Hutson T., Jonasch E., Joseph R.W., McDermott D.F., Motzer R.J., et al. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) J. Immunother. Cancer. 2019;7:354. doi: 10.1186/s40425-019-0813-8.
    1. Negishi T., Furubayashi N., Nakagawa T., Nishiyama N., Kitamura H., Hori Y., Kuroiwa K., Son Y., Seki N., Tomoda T., et al. Site specific response to Nivolumab in renal cell carcinoma. Anticancer Res. 2021;41:1539–1545. doi: 10.21873/anticanres.14913.
    1. Sbitti Y., Debbagh A., Slimani K., Mahi M., Errihani H., Ichou M. When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: A case report. J. Med. Case Rep. 2018;20:80. doi: 10.1186/s13256-018-1597-z.
    1. Chara L., Rodriguez B., Holgado E., Ramirez N., Fernandez-Rañada I., Mohedano N., Arcediano A., Garcia I., Cassinello J. An unusual metastatic renal cell carcinoma with maintained complete response to sunitinib treatment. Case Rep. Oncol. 2011;4:583–586. doi: 10.1159/000335016.
    1. Medioni J., Choueiri T.K., Zinzindohoué F., Cho D., Fournier L., Oudard S. Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: A retrospective analysis. J. Urol. 2009;181:2470–2475. doi: 10.1016/j.juro.2009.02.020.
    1. Négrier S., Escudier B., Gomez F., Douillard J.Y., Ravaud A., Chevreau C., Buclon M., Pérol D., Lasset C. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: A report from the Groupe Français d’Immunothérapie. Ann. Oncol. 2002;13:1460–1468. doi: 10.1093/annonc/mdf257.
    1. Vickers M.M., Al-Harbi H., Choueiri T.K., Kollmannsberger C., North S., MacKenzie M., Knox J.J., Rini B.I., Heng D.Y. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: Results from the international metastatic renal cell carcinoma database consortium. Clin. Genitourin. Cancer. 2013;11:311–315. doi: 10.1016/j.clgc.2013.04.012.
    1. Manola J., Royston P., Elson P., McCormack J.B., Mazumdar M., Négrier S., Escudier B., Eisen T., Dutcher J., Atkins M., et al. for the International Kidney Cancer Working Group. Prognostic model for survival in patients with metastatic renal cell carcinoma: Results from the International Kidney Cancer Working Group. Clin. Cancer Res. 2011;17:5443–5450. doi: 10.1158/1078-0432.CCR-11-0553.
    1. Grassi P., Verzoni E., Mariani L., De Braud F., Coppa J., Mazzaferro V., Procopio G. Prognostic role of pancreatic metastases from renal cell carcinoma: Results from an Italian center. Clin. Genitourin. Cancer. 2013;11:484–488. doi: 10.1016/j.clgc.2013.04.022.
    1. Kalra S., Atkinson B.J., Matrana M.R., Matin S.F., Wood C.G., Karam J.A., Tamboli P., Sircar K., Rao P., Corn P.G., et al. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU Int. 2016;117:761–765. doi: 10.1111/bju.13185.
    1. Chrom P., Stec R., Bodnar L., Szczylik C. Prognostic significance of pancreatic metastases from renal cell carcinoma in patients treated with tyrosine kinase inhibitors. Anticancer Res. 2018;38:359–365. doi: 10.21873/anticanres.12230.
    1. Dudani S., de Velasco G., Wells J.C., Gan C.L., Donskov F., Porta C., Pasini F., Lee J.L., Hansen A., Bjarnason G.A., et al. Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival. JAMA Netw. Open. 2021;4:e22021869. doi: 10.1001/jamanetworkopen.2020.21869.
    1. Shin T.J., Song C., Jeong C.W., Kwak C., Seo S., Kang M., Chung J., Hong S.H., Hwang E.C., Park J.Y., et al. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome. J. Surg. Oncol. 2021;123:204–213. doi: 10.1002/jso.26251.
    1. Shaya J.A., Lin X., Weise N., Cabal A., Panian J., Derweesh I.H., McKay R.R. Prognostic significance of pancreatic metastases in patients with advanced renal cell carcinoma treated with systemic therapy. Clin. Genitourin. Cancer. 2021;19:e367–e373. doi: 10.1016/j.clgc.2021.04.006.
    1. Piltz S., Meimarakis G., Wichmann M.W., Hatz R., Schildberg F.W., Fürst H. Surgical treatment of pulmonary metastases from renal cancer. Urologe A. 2003;42:1230–1237. doi: 10.1007/s00120-003-0329-0.
    1. Hofmann H.S., Neef H., Krohe K., Andreev P., Silber R.E. Prognostic factors and survival after pulmonary resection of metastatic renal carcinoma. Eur. Urol. 2005;48:77–81. doi: 10.1016/j.eururo.2005.03.004.
    1. Assouad J., Petkowa B., Berna B., Dujon A., Foucault C., Riquet M. Renal cell carcinoma lung metastases surgery: Pathologic findings and prognostic factors. Ann. Thorac. Surg. 2007;84:1114–1120. doi: 10.1016/j.athoracsur.2007.04.118.
    1. Winter H., Meimarakis G., Angele M.K., Hummel M., Staehler M., Hoffmann R.T., Hatz R.A., Löhe F. Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma. J. Urol. 2010;184:1888–1894. doi: 10.1016/j.juro.2010.06.096.
    1. Kanzaki R., Higashiyama M., Fujiwara A., Tokunaga T., Maeda J., Okami J., Nishimura K., Kodama K. Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: A 25-year single-institution experience. Eur. J. Cardiothorac. Surg. 2011;39:167–172. doi: 10.1016/j.ejcts.2010.05.021.
    1. Meimarakis G., Angele M., Staehler M., Clevert A., Crispin A., Rüttinger D., Löher F., Preissler G., Hatz R., Winter H. Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases. Am. J. Surg. 2011;202:158–167. doi: 10.1016/j.amjsurg.2010.06.029.
    1. Kawashima A., Nakayama M., Oka D., Sato M., Hatano K., Mukai M., Nagahara A., Nakai Y., Takayama H., Inoue M., et al. Pulmonary metastasectomy in patients with renal cell carcinoma: A single-institution experience. Int. J. Clin. Oncol. 2011;16:660–665. doi: 10.1007/s10147-011-0244-0.
    1. Kudelin N., Bölükbas S., Eberlein M., Schirren J. Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: An 11-year single-center experience. Ann. Thorac. Surg. 2013;96:265–270. doi: 10.1016/j.athoracsur.2013.04.047.
    1. Bölükbas S., Kudelin N., Eberlein M., Fisseler-Eckhoff A., Schirren J. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell. Thorac. Cardiovasc. Surg. 2012;60:390–397.
    1. Renaud S., Falcoz P.E., Alifano M., Olland A., Magdeleinat P., Pagès O., Regnard J.F., Massard G. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: An 18 years of experience. J. Surg. Oncol. 2014;109:823–829. doi: 10.1002/jso.23593.
    1. Saricam M. Factors Affecting Long-Term Survival Following Pulmonary Metastasectomy of Renal Cell Carcinoma. Urol. J. 2020;17:492–496.
    1. The Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear renal cell carcinoma. Nature. 2013;499:43–49. doi: 10.1038/nature12222.
    1. Mitchell T.J., Rossi S.H., Klatte T., Stewart G.D. Genomics and clinical correlates of renal cell carcinoma. World J. Urol. 2018;36:1899–1911. doi: 10.1007/s00345-018-2429-x.
    1. Eckel-Passow J.E., Serie D.J., Cheville J.C., Ho T.H., Kapur P., Brugarolas J., Thompson R.H., Leibovich B.C., Kwon E.D., Joseph R.W., et al. BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: Tumor heterogeneity and concordance with paired primary tumor. BMC Urol. 2017;17:19. doi: 10.1186/s12894-017-0209-3.
    1. Attalla K., Weng S., Voss M.H., Hakimi A.A. Epidemiology, risk Assessment, and biomarkers for patients with advanced renal cell carcinoma. Urol. Clin. N. Am. 2020;47:293–303. doi: 10.1016/j.ucl.2020.04.002.
    1. Carlo M.I., Manley B., Patil S., Woo K.M., Coskey D.T., Redzematovic A., Arcila M., Ladanyi M., Lee W., Chen Y.B., et al. Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma. Kidney Cancer. 2017;1:49–56. doi: 10.3233/KCA-160003.
    1. Voss M.H., Reising A., Cheng Y., Patel P., Marker M., Kuo F., Chan T.A., Choueiri T.K., Hsieh J.J., Hakimi A.A., et al. Genomically annotated risk model for advanced renal-cell carcinoma: A retrospective cohort study. Lancet Oncol. 2018;19:1688–1698. doi: 10.1016/S1470-2045(18)30648-X.
    1. Turajlic S., Xu H., Litchfield K., Rowan A., Chambers T., Lopez J.I., Nicol D., O’Brien T., Larkin J., Horswell S., et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell. 2018;173:581–594.e12. doi: 10.1016/j.cell.2018.03.057.
    1. Turajlic S., Swanton C., Boshoff C. Kidney cancer: The next decade. J. Exp. Med. 2018;215:2477–2479. doi: 10.1084/jem.20181617.
    1. Kotecha R.R., Motzer R.J., Voss M.H. Towards individualized therapy for metastatic renal cell carcinoma. Nat. Rev. Clin. Oncol. 2019;16:621–633. doi: 10.1038/s41571-019-0209-1.
    1. Gu Y.-F., Cohn S., Christie A., McKenzie T., Wolff N., Do Q.N., Madhuranthakam A.J., Pedrosa I., Wang T., Dey A., et al. Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor grade. Cancer Discov. 2017;7:900–917. doi: 10.1158/-17-0292.
    1. Hakimi A.A., Ostrovnaya I., Reva B., Schultz N., Chen Y.B., Gonen M., Liu H., Takeda S., Voss M.H., Satish K., et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA Research Network. Clin. Cancer Res. 2013;19:3259–3267. doi: 10.1158/1078-0432.CCR-12-3886.
    1. Wang S.S., Gu Y.N., Wolff N., Stefanius K., Christie A., Dey A., Hammer R.E., Xie X.J., Rakheja D., Pedrosa I., et al. Bap1 is essential for kidney function and cooperates with VHL in renal tumorigenesis. Proc. Natl. Acad. Sci. USA. 2014;111:16538–16543. doi: 10.1073/pnas.1414789111.
    1. Wang T., Lu R., Kapur P., Jaiswal B.S., Hannan R., Zhang Z., Pedrosa I., Luke J.J., Zhang H., Goldstein L.D., et al. An empirical approach leveraging tumorgrafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors. Cancer Discov. 2018;8:1142–1155. doi: 10.1158/-17-1246.
    1. Laruelle A., Manini C., Iñarra E., López J.I. Metastasis, an example of evolvability. Cancers. 2021;13:3653. doi: 10.3390/cancers13153653.
    1. Murugan N.J., Voutsadakis I.A. Proteasome regulators in pancreatic cancer. World J. Gastrointest. Oncol. 2022;14:38–54. doi: 10.4251/wjgo.v14.i1.38.
    1. Pelosi E., Castelli G., Testa U. Pancreatic cancer: Molecular characterization, clonal evolution and cancer stem cells. Biomedicines. 2017;5:65. doi: 10.3390/biomedicines5040065.
    1. Aguirre A.J., Nowak J.A., Camarda N.D., Moffitt R.A., Ghazani A.A., Hazar-Rethinam M., Raghavan S., Kim J., Brais L.K., Ragon D., et al. Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine. Cancer Discov. 2018;8:1096–1111. doi: 10.1158/-18-0275.
    1. The Cancer Genome Atlas Research Network Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017;32:185–203.e13. doi: 10.1016/j.ccell.2017.07.007.
    1. McIntyre C.A., Sharon A., Lawrence S.A., Richards A.L., Chou J.F., Wong W., Capanu M., Berger M.F., Donoghue M.T., Varghese A.M., et al. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. Cancer. 2020;126:3939–3949. doi: 10.1002/cncr.33038.
    1. Yachida S., White C.M., Naito Y., Zhong Y., Brosnan J.A., Macgregor-Das A.M., Morgan R.A., Saunders T., Laheru D.A., Herman J.M., et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of long-term survivors. Clin. Cancer Res. 2012;18:6339–6347. doi: 10.1158/1078-0432.CCR-12-1215.
    1. Bailey P., Chang D.K., Nones K., Johns A.L., Patch A.M., Gingras M.C., Miller D.K., Christ A.N., Bruxner T.J., Quinn M.C., et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47–52. doi: 10.1038/nature16965.
    1. Moffitt R.A., Marayati R., Flate E.L., Volmar K.E., Loeza S.G., Hoadley K.A., Naim U.R., Lindsay A.W., Eaton S.C., Chung A.H., et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 2015;47:1168–1178. doi: 10.1038/ng.3398.
    1. Waddell N., Pajic M., Patch A.M., Chang D.K., Kassahn K.S., Bailey P., Johns A.L., Miller D., Nones K., Quek K., et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495–501. doi: 10.1038/nature14169.
    1. Wang J.D., Jin K., Chen X.Y., Lv J.Q., Ji K.W. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: A systematic review and meta-analysis. Oncotarget. 2017;8:16704–16711. doi: 10.18632/oncotarget.14335.
    1. Dal Molin M., Zhang M., de Wilde R.F., Ottenhof N.A., Rezaee N., Wolfgang C.L., Blackford A., Vogelstein B., Kinzler K.W., Papadopoulos N., et al. Very long-term survival following resection for pancreatic cancer Is not explained by commonly mutated genes: Results of whole-exome sequencing analysis. Clin. Cancer Res. 2015;21:1944–1950. doi: 10.1158/1078-0432.CCR-14-2600.
    1. Endo H., Inoue M. Dormancy in cancer. Cancer Sci. 2019;110:474–480. doi: 10.1111/cas.13917.
    1. Summers M.A., McDonald M.M., Croucher P.I. Cancer cell dormancy in metastasis. Cold Spring Harb. Perspect. Med. 2020;10:a037556. doi: 10.1101/cshperspect.a037556.
    1. Gao Y., Bado I., Wang H., Zhang W., Rosen J.M., Zhang X.H. Metastasis organotropism: Redefining the congenial soil. Dev. Cell. 2019;49:375–391. doi: 10.1016/j.devcel.2019.04.012.
    1. Gerlinger M., Rowan A.J., Horswell S., Math M., Larkin J., Endesfelder D., Gronroos E., Martinez P., Matthews N., Stewart A., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012;366:883–892. doi: 10.1056/NEJMoa1113205.
    1. Jonasch E., Gao J., Rathmell W.K. Renal cell carcinoma. BMJ. 2014;349:g4797. doi: 10.1136/bmj.g4797.
    1. Dasgupta P., Kulkarni P., Majid S., Varahram S., Hashimoto Y., Bhat N.S., Shiina M., Deng G., Saini S., Tabatabai Z.L., et al. MicroRNA-203 inhibits long noncoding RNA HOTAIR and regulates tumorigenesis through epithelial- to-mesenchymal transition pathway in renal cell carcinoma. Mol. Cancer Ther. 2018;17:1061–1069. doi: 10.1158/1535-7163.MCT-17-0925.
    1. Ji S., Zhang X., Han Z., Zhao Y., Lu Q. MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma. Oncol. Lett. 2019;17:2400–2408. doi: 10.3892/ol.2018.9871.
    1. Wang M., Sun Y., Xu J., Lu J., Wang K., Yang D.R., Yang G., Li G., Chang C. Preclinical studies using miR-32-5p to suppress clear cell renal carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling. Int. J. Cancer. 2018;143:100–112. doi: 10.1002/ijc.31289.
    1. Ding X. MicroRNAs: Regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) Chin. J. Cancer. 2014;33:140–146. doi: 10.5732/cjc.013.10094.
    1. Li Y., Chen D., Su Z., Li Y., Liu J., Jin L., Shi M., Jiang Z., Qi Z., Gui Y., et al. MicroRNA 106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis. Mol. Med. Rep. 2016;13:1420–1426. doi: 10.3892/mmr.2015.4656.
    1. Su Z., Chen D., Zhang E., Li Y., Yu Z., Shi M., Jiang Z., Ni L., Yang S., Gui Y., et al. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma. Mol. Med. Rep. 2015;12:1535–1543. doi: 10.3892/mmr.2015.3498.
    1. Gu C., Wang Z., Jin Z., Li G., Kou Y., Jia Z., Yang J., Tian F. MicroRNA-212 inhibits the proliferation, migration ad invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP) Oncotarget. 2017;8:92119–92133. doi: 10.18632/oncotarget.20786.
    1. Yamasaki T., Seki N., Yoshino H., Itesako T., Hidaka H., Yamada Y., Tatarano S., Yonezawa T., Kinoshita T., Nakagawa M., et al. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J. Urol. 2013;190:1059–1068. doi: 10.1016/j.juro.2013.02.089.
    1. Wei R., Ye X., Zhao Y., Jia N., Liu T., Lian W., Wei H., Zhang G., Song L. MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A. Oncol. Lett. 2019;17:3211–3218. doi: 10.3892/ol.2019.9986.
    1. Shiomi E., Sugai T., Ishida K., Osakabe M., Tsuyukubo T., Kato Y., Takata R., Obara W. Analysis of expression patterns of microRNAs that are closely associated with renal carcinogenesis. Front. Oncol. 2019;9:431. doi: 10.3389/fonc.2019.00431.
    1. Xiao W., Wang X., Wang T., Xing J. MIR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma. Aging. 2019;11:615–631. doi: 10.18632/aging.101763.
    1. He C., Chen Z.Y., Li Y., Yang Z.Q., Zeng F., Cui Y., He Y., Chen J.B., Chen H.Q. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signalling pathway in clear-cell renal cell carcinoma. BMC Nephrol. 2019;20:127. doi: 10.1186/s12882-019-1322-1.
    1. Zhou H., Tang K., Liu H., Zeng J., Li H., Yan L., Hu J., Guan W., Chen K., Xu H., et al. Regulatory network of two tumor-suppressive noncoding RNAs interferes with the growth and metastasis of renal cell carcinoma. Mol. Ther. Nucleic Acids. 2019;16:554–565. doi: 10.1016/j.omtn.2019.04.005.
    1. Heinzelmann J., Unrein A., Wickmann U., Baumgart S., Stapf M., Szendroi A., Grimm M.O., Gajda M., Wunderlich H., Junker K. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: A comparison of primary tumors and distant metastases. Ann. Surg. Oncol. 2014;21:1046–1054. doi: 10.1245/s10434-013-3361-3.
    1. Kowalik C.G., Palmer D.A., Sullivan T.B., Teebagy P.A., Dugan J.M., Libertino J.A., Burks E.J., Canes D., Rieger-Christ K.M. Profiling microRNA from nephrectomy and biopsy specimens: Predictors of progression and survival in clear cell renal cell carcinoma. BJU Int. 2017;120:428–440. doi: 10.1111/bju.13886.
    1. Yuan J., Dong R., Liu F., Zhan L., Liu Y., Wei J., Wang N. The miR-183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma. Exp. Ther. Med. 2019;17:2457–2464. doi: 10.3892/etm.2019.7221.
    1. Wu X., Weng L., Li X., Guo C., Pal S.K., Jin J.M., Li Y., Nelson R.A., Mu B., Onami S.H., et al. Identification of a 4-microRNA signature for clear cell renal carcinoma metastasis and prognosis. PLoS ONE. 2012;7:e35661. doi: 10.1371/journal.pone.0035661.
    1. Yu L., Xiang L., Feng J., Li B., Zhou Z., Li J., Lin Y., Lv Y., Zou D., Lei Z., et al. miRNA-21 and miRNA-223 expression singnature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma. J. Cancer. 2018;9:3651–3659. doi: 10.7150/jca.27117.
    1. Mlcochova H., Machackova T., Rabien A., Radova L., Fabian P., Iliev R., Slaba K., Poprach A., Kilic E., Stanik M., et al. Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma. Sci. Rep. 2016;6:31852. doi: 10.1038/srep31852.
    1. Heinzelmann J., Arndt M., Pleyers R., Fehlmann T., Hoelters S., Zeuschner P., Vogt A., Pryalukhin A., Schaeffeler E., Bohle R.M., et al. 4-miRNA score predicts the individual metastatic risk of renal cell carcinoma patients. Ann. Surg. Oncol. 2019;26:3765–3773. doi: 10.1245/s10434-019-07578-3.
    1. Talmadge J.E., Fidler I.J. AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res. 2010;70:5649–5669. doi: 10.1158/0008-5472.CAN-10-1040.
    1. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820–827. doi: 10.1038/nature04186.
    1. Sceneay J., Smyth M., Möller A. The pre-metastatic niche: Finding common ground. Cancer Metastasis Rev. 2013;32:449–464. doi: 10.1007/s10555-013-9420-1.
    1. Liu Y., Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016;30:668–681. doi: 10.1016/j.ccell.2016.09.011.
    1. Wang Y., Ding Y., Guo N., Wang S. MDSCs: Key criminals of tumor pre-metastatic niche formation. Front. Immunol. 2019;10:172. doi: 10.3389/fimmu.2019.00172.
    1. Grange C., Brossa A., Bussolatti B. Extracellular vesicles and carried miRNAs in the progression of renal cell carcinoma. Int. J. Mol. Sci. 2019;20:1832. doi: 10.3390/ijms20081832.
    1. Gai C., Pomatto M.A., Grange C., Deregibus M.C., Camussi G. Extracellular vesicles in onco-nephrology. Exp. Mol. Med. 2019;51:29. doi: 10.1038/s12276-019-0213-7.
    1. Wortzel I., Dror S., Kenific C.M., Lyden D. Exosome-mediated metastasis: Communication from a distance. Dev. Cell. 2019;49:347–360. doi: 10.1016/j.devcel.2019.04.011.
    1. Nan X., Wang J., Liu H.N., Wong S.T., Zhao H. Epithelial-mesenchymal plasticity in organotropism metastasis and tumor immune escape. J. Clin. Med. 2019;8:747. doi: 10.3390/jcm8050747.
    1. Grange C., Tapparo M., Collino F., Vitillo L., Damasco C., Deregibus M.C., Tetta C., Bussolati B., Camussi G. Microvesicles released from human renal cancer stem cells stimulate angiogensis and formation of lung premetastatic niche. Cancer Res. 2011;71:5346–5356. doi: 10.1158/0008-5472.CAN-11-0241.
    1. Peinado H., Zhang H., Matei I.R., Costa-Silva B., Hoshino G., Rodrigues G., Psaila B., Kaplan R.N., Bromberg J.F., Kang Y., et al. Pre-metastatic niches: Organ-Specific homes for metastases. Nat. Rev. Cancer. 2017;17:302–317. doi: 10.1038/nrc.2017.6.
    1. Massague J., Obenauf A.C. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298. doi: 10.1038/nature17038.
    1. Elhilali M., Gleave M., Fradet Y., Venner D., Saad F., Klotz L., Moore R., Paton E. Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon γ-1b for the treatment of metastatic renal cell carcinoma. BJU. Int. 2000;86:613–618. doi: 10.1046/j.1464-410x.2000.00880.x.
    1. Snow R.M., Schellhammer P.F. Spontaneous regression of metastatic renal cell carcinoma. Urology. 1982;20:177. doi: 10.1016/0090-4295(82)90356-9.
    1. Bloom H.J. Hormone induced and spontaneous regression of metastatic renal cancer. Cancer. 1973;32:1666. doi: 10.1002/1097-0142(197311)32:5<1066::AID-CNCR2820320507>;2-F.
    1. Walenkamp A.M., Lapa C., Herrmann K., Wester H.J. CXCR4 ligands: The next big hit? J. Nucl. Med. 2017;58:77S–82S. doi: 10.2967/jnumed.116.186874.
    1. Chambers A.F., Groom A.C., MacDonald I.C. Metastasis: Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer. 2002;2:563–572. doi: 10.1038/nrc865.
    1. Schild T., Low V., Blenis J., Gomes A.P. Unique metabolic adaptations dictate distal organ-specific metastatic colonization. Cancer Cell. 2018;33:347–354. doi: 10.1016/j.ccell.2018.02.001.
    1. Ebert D., Haller R.G., Walton M.E. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 2003;23:5928–5935. doi: 10.1523/JNEUROSCI.23-13-05928.2003.
    1. Da Silva R.P., Nissim I., Brosnan J.T. Creatine synthesis: Hepatic metabolism of guanidinacetate and creatine in the rat in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 2009;296:E256–E261. doi: 10.1152/ajpendo.90547.2008.
    1. Mashimo T., Pichumani K., Vemireddy V., Hatanpaa K.J., Singh D.K., Sirasanagandla S., Nannepaga S., Piccirillo S.G., Kovacs Z., Foong C., et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell. 2014;159:1603–1614. doi: 10.1016/j.cell.2014.11.025.
    1. Chen J., Lee H.J., Wu X., Huo L., Kim S.J., Xu L., Wang Y., He J., Bollu L.R., Gao G., et al. Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. Cancer Res. 2015;75:554–565. doi: 10.1158/0008-5472.CAN-14-2268.
    1. Wang C., Luo D. The metabolic adaptation mechanism of metastatic organotropism. Exp. Hematol. Oncol. 2021;10:30. doi: 10.1186/s40164-021-00223-4.
    1. Jiao L., Zhang H.L., Li D.D., Yang K.L., Tang J., Li X., Ji J., Yu Y., Wu R.Y., Ravichandran S., et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2) Autophagy. 2018;14:671–684. doi: 10.1080/15548627.2017.1381804.
    1. Hashim A.I., Zhang X., Wojtkowiakk J.W., Gillies R.J. Imaging pH and metastasis. NMR Biomed. 2011;24:582–591. doi: 10.1002/nbm.1644.
    1. Thews O., Riemann A. Tumor pH and metastasis: A malignant process beyond hypoxia. Cancer Metastasis Rev. 2019;38:113–129. doi: 10.1007/s10555-018-09777-y.
    1. Fischer K., Hoffmann P., Voelkl S., Meidenbauer N., Ammer J., Edinger M., Gottfried E., Schwarz S., Rothe G., Hoves S., et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109:3812–3819. doi: 10.1182/blood-2006-07-035972.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다